TFA
SRNE

Toth Financial Advisory’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Toth Financial Advisory’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-300
Closed -$1K – 799
2022
Q1 		$1K Hold
300
– – ﹤0.01% 703
2021
Q4 		$1K Sell
300
-300
-50% -$1.86K ﹤0.01% 734
2021
Q3 		$5K Sell
600
-1,350
-69% -$11.4K ﹤0.01% 565
2021
Q2 		$19K Hold
1,950
– – ﹤0.01% 388
2021
Q1 		$16K Hold
1,950
– – ﹤0.01% 420
2020
Q4 		$13K Buy
1,950
+300
+18% +$2.41K ﹤0.01% 387
2020
Q3 		$18K Buy
1,650
+1,350
+450% +$12.4K ﹤0.01% 327
2020
Q2 		$2K Buy
+300
New +$1.15K ﹤0.01% 488

Other funds holding SRNE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return